By Chris Wack
Annovis Bio shares were down 17% at $6.74 after the company priced an underwritten public offering of 1.25 million units consisting of one share and an accompanying warrant.
The stock hit its 52-week low of $6.60 earlier in the session, and is down 47% in the past 12 months.
The…
Read the full article here
